Starflick.Com Announces Joint Collaboration with Triton Films Inc.

July 14, 2014 12:57 PM EDT | Source: Lotus Bio-Technology Development, Corp.

Point Roberts, Washington--(Newsfile Corp. - July 14, 2014) - Starflick.Com Inc. (OTCQB: STFKD) is pleased to announce a strategic relationship has been formed with Internationally renowned film production company Triton Films (www.tritonfilms.net) for the creation and production of 7 intellectual property titles that are to be created and offered for sale to Major Studios. The Starflick/Triton lucrative business model will take proof-of-concept content and develop scripts and trailers to be sold to majors that complete the films. Terms of the deal is $100,000 payable to Triton.

Triton Films is a successful company that has made major intellectual property sales to renowned production companies such as Paramount Pictures, Lionsgate Entertainment and several other major film studios.

Triton Films Inc. has launched the careers of directors such as Neill Blomkamp (District 9) and Cinematographer Trent Opaloch (Captain America: The Winter Soldier).

Triton Films is currently shooting the feature film JUAREZ 2045 with Danny Trejo in Utah, followed by an action film with Steve Austin.

About Starflick.Com Inc.

Starflick.com Inc. is a Point Roberts, WA based Film/Distribution Company that specializes in the production of independent films and documentaries. Our mandate is to identify projects that strike a balance between artistic integrity and commercial viability for the international market and to develop strong relationships with independent filmmakers that will assist them in bringing their vision to fruition while ensuring a solid financial return for our shareholders. Starflick.Com Inc is a publicly traded company having its common shares quoted on the OTC Markets under the symbol STFKD.

Corporate Webpage: www.Starflick.com

Forward Looking Statements

Cautionary Statement Regarding "Forward-Looking" Information
Some of the statements contained in this press release are forward-looking statements and information within the meaning of applicable securities laws. Forward-looking statements and information can be identified by the use of words such as "expects", "intends", "is expected", "potential", "suggests" or variations of such words or phrases, or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements and information are not historical facts and are subject to a number of risks and uncertainties beyond the Company's control. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this news release. Accordingly, readers should not place undue reliance on forward-looking statements. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, except as may be required by law.

Contact:
Zoltan Nagy
President, Starflick.Com Inc.
604 783 9664

info

Source: Lotus Bio-Technology Development, Corp.

Prêt à annoncer en toute confiance?

Envoyez-nous un message, et un membre de notre équipe TMX Newsfile communiquera avec vous pour discuter de vos besoins.

Communiquez avec nous